[go: up one dir, main page]

FR2916141B1 - RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO. - Google Patents

RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO.

Info

Publication number
FR2916141B1
FR2916141B1 FR0703492A FR0703492A FR2916141B1 FR 2916141 B1 FR2916141 B1 FR 2916141B1 FR 0703492 A FR0703492 A FR 0703492A FR 0703492 A FR0703492 A FR 0703492A FR 2916141 B1 FR2916141 B1 FR 2916141B1
Authority
FR
France
Prior art keywords
malvidine
polyarthritis
glucoside
vivo
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0703492A
Other languages
French (fr)
Other versions
FR2916141A1 (en
Inventor
Jean Michel Merillon
Mohammad Djavad Mossalayi
Virginie Aumont
Alain Decendit
Teguo Pierre Waffo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Victor Segalen Bordeaux 2
Original Assignee
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Victor Segalen Bordeaux 2 filed Critical Universite Victor Segalen Bordeaux 2
Priority to FR0703492A priority Critical patent/FR2916141B1/en
Publication of FR2916141A1 publication Critical patent/FR2916141A1/en
Application granted granted Critical
Publication of FR2916141B1 publication Critical patent/FR2916141B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0703492A 2007-05-15 2007-05-15 RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO. Expired - Fee Related FR2916141B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0703492A FR2916141B1 (en) 2007-05-15 2007-05-15 RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703492A FR2916141B1 (en) 2007-05-15 2007-05-15 RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO.

Publications (2)

Publication Number Publication Date
FR2916141A1 FR2916141A1 (en) 2008-11-21
FR2916141B1 true FR2916141B1 (en) 2009-11-13

Family

ID=39159209

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703492A Expired - Fee Related FR2916141B1 (en) 2007-05-15 2007-05-15 RHEUMATOID ANTI-POLYARTHRITIS ACTIVITY OF MALVIDINE -3-O-BETA-GLUCOSIDE IN VIVO.

Country Status (1)

Country Link
FR (1) FR2916141B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229631A (en) * 2011-05-03 2011-11-02 西安瑞联近代电子材料有限责任公司 Method for separating and purifying malvidin glucoside from grape-skin red

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2979826B1 (en) 2011-09-08 2013-12-27 Univ Bordeaux Segalen ANTI-INFLAMMATORY COMPOSITION
CN115590874A (en) * 2022-12-12 2023-01-13 汤臣倍健股份有限公司（Cn） Application of malvidin-3-O-glucoside in preparation of medicines or health-care foods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060123663A (en) * 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 Compositions Containing Natural Cyclooxygenase Inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229631A (en) * 2011-05-03 2011-11-02 西安瑞联近代电子材料有限责任公司 Method for separating and purifying malvidin glucoside from grape-skin red
CN102229631B (en) * 2011-05-03 2014-06-18 西安瑞联近代电子材料有限责任公司 Method for separating and purifying malvidin glucoside from grape-skin red

Also Published As

Publication number Publication date
FR2916141A1 (en) 2008-11-21

Similar Documents

Publication Publication Date Title
BRPI0722004A2 (en) Health Center.
EP1855738A4 (en) CATHETER CONNECTION
DK2130518T3 (en) Porous femoral titanium bushes
BRPI0919058A2 (en) independent biological indicator
DK3178319T3 (en) EX VIVO ORGAN CARE SYSTEMS
BRPI0817313A2 (en) Tetramic and tetronic acid haloalkoxypyrocyclic derivatives
EP2049713A4 (en) TISSUE REJECTION
BRPI0813425A2 (en) BLOOD JOINT
DK2094029T3 (en) Implantable transducer
DE602009000580D1 (en) endoscope system
DE602006004866D1 (en) CATHETER
DE602007004361D1 (en) endoscope system
FI20085173L (en) Heart rate detection
IT1391555B1 (en) EXTRACORPOREO BLOOD TREATMENT SYSTEM
DK2094292T3 (en) SALPETEROXIDE-BLOCKED CROSS-TETRAMERIC HEMOGLOBIN
EP2176763A4 (en) GROUP OF MEMORY TRANSACTIONS
FR2898636B1 (en) STRUCTURE OF TAIL-OF BROWN RADIUS.
EP2060887A4 (en) PHOTODETECTOR
BRPI0920392A2 (en) blood reservoir
BRPI0910853A2 (en) air-opening capsule
DK1987765T3 (en) Oximeter
BRPI0913449A2 (en) support platform.
EP2356145A4 (en) FULLY HUMAN ANTIBODIES DIRECTED AGAINST N-ACHHERINE
DE602006004919D1 (en) endoscope system
EP2230301A4 (en) NOVEL GLUCOSE EDHYDROGENASE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170131